biotech investing

Key Highlights Q4 revenue of $8.6 billion increased 0.5% as reported and 5.4% organic Q4 GAAP diluted earnings per share (EPS) of $0.49 ; non-GAAP diluted EPS of $1.46 FY24 revenue of $32.4 billion increased 3.6% as reported…
Read More...